I got a reply. No direct sales to individuals. They want to start with clinical trails in Australia first and will follow a Channel sales model. They might review this at a later stage.
Ann: Ellipta Production and Market Release, page-7
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
0.001(6.25%) |
Mkt cap ! $12.41M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.7¢ | 1.6¢ | $946 | 55.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 101 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 703695 | 4 |
View Market Depth
| Last trade - 13.57pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
1.6¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 1.6¢ | 1.7¢ | 1.6¢ | 269283 | ||
| Last updated 14.58pm 17/06/2024 ? | |||||
| ADR (ASX) Chart |
